GET DAILY SIGNALSAxon Enterprise (AXON): Assessing the Road to the $560 Price Target
Key Takeaways
- The central $560 stock price target is the arithmetic mean of roughly 21 current analyst price targets reviewed for Axon Enterprise, Inc.
- At a recent price near $313, reaching $560 would require roughly 79% upside, a very large move.
- Analyst targets span a wide range of about $380 to $700, reflecting genuine disagreement after a guidance cut.
- The strongest supports are fast-growing software and annual recurring revenue (ARR), plus $15.8 billion in contracted bookings.
- The biggest risks are delayed federal counter-drone deals, weak free cash flow (FCF), and a premium valuation.
- Get more context on the ticker's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
- Explore Trending AI Robots for AI-driven trade ideas across the market.
What Analysts Are Targeting for AXON
Axon Enterprise, Inc. (AXON) is a public safety technology company, not an exchange-traded fund. It develops TASER conducted-energy weapons, body cameras, cloud-based digital evidence management, and counter-drone systems.
The $560 central target reflects the average of roughly 21 current analyst price targets, which range from about $380 to $700. The Street view remains bullish overall, with a consensus rating near "Buy," but the range is unusually wide. Cautious names sit at the low end—UBS reiterated a Hold with a $380 target—while the most optimistic, such as Citizens JMP near $700, expect the counter-drone and software businesses to reaccelerate.
The targets were materially reset after third-quarter results. On November 6, several firms cut targets while keeping Buy or Outperform ratings: JPMorgan to $610 from $755, RBC Capital to $615 from $735, TD Cowen to $650 from $800, Needham to $500 from $750, Raymond James to $475 from $675, Barclays to $507 from $688, and Piper Sandler to $540 from $561. Craig-Hallum downgraded the stock to Hold. Analysts generally cite software durability on one side and hardware and margin volatility on the other.
Where the Stock Stands Today and What It Would Take
The stock closed near $313 after an 18% single-day decline following its November 5 earnings report, leaving shares down roughly 45% for the year. Reaching $560 would require about 79% upside, a very large move that implies both restored earnings growth and a higher valuation multiple.
The path depends on fundamentals. Third-quarter revenue rose 28% year over year to about $909 million, but missed estimates, and earnings per share (EPS) also came in light. Management lowered full-year revenue guidance to roughly $3.61–$3.63 billion and cut its FCF outlook to $350–$400 million. Still, software and services revenue grew 43%, ARR rose 40% to $1.8 billion, and contracted bookings reached $15.8 billion, suggesting recurring demand remains intact.
On valuation, AXON trades at a premium—roughly 35 times next-twelve-month earnings at the recent price, well below its five-year average near 77 times—so multiple compression has already occurred. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Factors That Could Support a Move Higher
- Recurring software momentum: 43% software and services growth and 40% ARR growth underpin the long-term bull case.
- A $15.8 billion contracted bookings backlog provides multi-year revenue visibility.
- Counter-drone (Dedrone) demand is described by management as delayed, not canceled, leaving room for recovery.
- An expanded investment in drone maker Skydio positions the company for future defense and security growth.
- Broad analyst support, with most firms maintaining Buy or Outperform ratings despite lower targets.
Key Risks That Could Hold the Stock Back
- Federal counter-drone deals slipped on procurement timing and election-cycle dynamics, and further slippage could recur.
- Cash conversion is weak: FCF fell to about $75 million in 2025 from roughly $330 million in 2024, and was negative in the first half of 2026.
- A $1.15 billion convertible note offering and the Skydio commitment add dilution and cash-outlay risk.
- Hardware margin pressure and a premium valuation leave the shares vulnerable to further compression if growth disappoints.
Technical Picture and Levels to Watch
The earnings-driven selloff broke the stock below its prior trading zone near $380–$420, leaving a gap from roughly $383 down to the low $300s. The $300 area now stands as a psychological support level, while the gap zone and prior range form overhead resistance that would need to be reclaimed before a sustained move toward $560 becomes technically credible.
Time Horizon and Items to Monitor
Analyst price targets typically reflect a roughly 12-month research horizon, though individual assumptions vary. Key items to watch include fourth-quarter results and the company's ~$450 million FCF goal, whether delayed federal counter-drone revenue is realized, the timing of Skydio deal closings through early 2027, analyst revisions, and broader sentiment toward high-multiple growth stocks. From what I see, this is important because it highlights where the real uncertainty lies.
Using Tickeron’s AI Daily Buy/Sell Signals in Practice
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to uncover opportunities, keep an eye on existing positions, and spot changing trends more efficiently than manual screening. Consider pairing these AI signals with your own research on AXON to stay ahead of evolving market conditions.
Final Thoughts
The $560 target is the average of current analyst price targets, not a guarantee, and it implies roughly 79% upside from the recent $313 price—a very large move. Support comes from durable software and ARR growth and a deep bookings backlog, while the principal obstacles are delayed federal counter-drone revenue, weak free cash flow, and a premium valuation. Wide analyst disagreement—targets ranging from $380 to $700—underscores real uncertainty. Investors should watch cash flow, guidance, and whether deferred deals ultimately close before drawing conclusions about a move toward $560.
Exploring Tickeron AI Tools for Deeper Analysis
In my own research process, I often turn to Tickeron’s suite of AI tools to cross-check analyst views and identify patterns in stocks like AXON. The platform’s AI Trend Prediction Engine and Pattern Search Engine help me quickly scan for technical setups and compare performance across peers without spending hours on manual charts. It’s become a regular part of how I evaluate opportunities in growth names where fundamentals and sentiment can shift quickly.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AXON's RSI Indicator slumps oversold zone
The RSI Indicator for AXON moved into overbought territory on November 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 55 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 32 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a clinical-stage biopharmaceutical company
Industry AerospaceDefense
Advertisement